These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28091672)

  • 21. In vitro selection of anti-Akt2 thioether-macrocyclic peptides leading to isoform-selective inhibitors.
    Hayashi Y; Morimoto J; Suga H
    ACS Chem Biol; 2012 Mar; 7(3):607-13. PubMed ID: 22273180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lead discovery and optimization strategies for peptide macrocycles.
    Bhat A; Roberts LR; Dwyer JJ
    Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Minimal RNA Substrate of Flexizymes.
    Fujino T; Kondo T; Suga H; Murakami H
    Chembiochem; 2019 Aug; 20(15):1959-1965. PubMed ID: 30950544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of nonstandard macrocyclic peptide ligands through display screening.
    Taylor RD; Rey-Carrizo M; Passioura T; Suga H
    Drug Discov Today Technol; 2017 Dec; 26():17-23. PubMed ID: 29249238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids.
    Frost JR; Jacob NT; Papa LJ; Owens AE; Fasan R
    ACS Chem Biol; 2015 Aug; 10(8):1805-16. PubMed ID: 25933125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides.
    Kawakami T; Murakami H; Suga H
    Chem Biol; 2008 Jan; 15(1):32-42. PubMed ID: 18215771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mysteries of macrocyclic colibactins.
    Carlson ES; Balskus EP
    Nat Chem; 2019 Oct; 11(10):867-869. PubMed ID: 31548675
    [No Abstract]   [Full Text] [Related]  

  • 28. Ribosomal synthesis of peptides with C-terminal lactams, thiolactones, and alkylamides.
    Nakajima E; Goto Y; Sako Y; Murakami H; Suga H
    Chembiochem; 2009 May; 10(7):1186-92. PubMed ID: 19370739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus.
    Ohuchi M; Murakami H; Suga H
    Curr Opin Chem Biol; 2007 Oct; 11(5):537-42. PubMed ID: 17884697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flexizymes, their evolutionary history and diverse utilities.
    Passioura T; Suga H
    Top Curr Chem; 2014; 344():331-45. PubMed ID: 23478876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of macrocyclic organo-peptide hybrids from ribosomal polypeptide precursors via CuAAC-/hydrazide-mediated cyclization.
    Smith JM; Fasan R
    Methods Mol Biol; 2015; 1248():23-38. PubMed ID: 25616323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New potent and selective αvβ
    Wu Z; Cheng X; Hong H; Zhao X; Zhou Z
    Bioorg Med Chem Lett; 2017 May; 27(9):1911-1913. PubMed ID: 28351594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrocyclic helix-threading peptides for targeting RNA.
    Krishnamurthy M; Simon K; Orendt AM; Beal PA
    Angew Chem Int Ed Engl; 2007; 46(37):7044-7. PubMed ID: 17691090
    [No Abstract]   [Full Text] [Related]  

  • 34. A flexizyme that selectively charges amino acids activated by a water-friendly leaving group.
    Niwa N; Yamagishi Y; Murakami H; Suga H
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3892-4. PubMed ID: 19364647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovering functional, non-proteinogenic amino acid containing, peptides using genetic code reprogramming.
    Rogers JM; Suga H
    Org Biomol Chem; 2015 Sep; 13(36):9353-63. PubMed ID: 26280393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translation initiation by using various N-acylaminoacyl tRNAs.
    Goto Y; Ashigai H; Sako Y; Murakami H; Suga H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):293-4. PubMed ID: 17150933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Selection of Macrocyclic l-α/d-α/β/γ-Hybrid Peptides Targeting IFN-γ/IFNGR1 Protein-Protein Interaction.
    Miura T; Lee KJ; Katoh T; Suga H
    J Am Chem Soc; 2024 Jul; 146(26):17691-17699. PubMed ID: 38888290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide Display Technologies.
    Pitt A; Nims Z
    Methods Mol Biol; 2019; 2001():285-298. PubMed ID: 31134576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Charging of tRNAs using ribozymes and selection of cyclic peptides containing thioethers.
    Reid PC; Goto Y; Katoh T; Suga H
    Methods Mol Biol; 2012; 805():335-48. PubMed ID: 22094815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges.
    Sawyer TK; Partridge AW; Kaan HYK; Juang YC; Lim S; Johannes C; Yuen TY; Verma C; Kannan S; Aronica P; Tan YS; Sherborne B; Ha S; Hochman J; Chen S; Surdi L; Peier A; Sauvagnat B; Dandliker PJ; Brown CJ; Ng S; Ferrer F; Lane DP
    Bioorg Med Chem; 2018 Jun; 26(10):2807-2815. PubMed ID: 29598901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.